Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities

A series of novel β-carboline-based hydroxamate derivatives (8a–n) as HDAC inhibitors have been designed and synthesized.